Macular Degeneration (AMD) and Other Retinal Diseases Market, Global Outlook and Forecast 2023-2032
The global Macular Degeneration (AMD) and Other Retinal Diseases market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands.
This report aims to provide a comprehensive presentation of the global market for Macular Degeneration (AMD) and Other Retinal Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macular Degeneration (AMD) and Other Retinal Diseases. This report contains market size and forecasts of Macular Degeneration (AMD) and Other Retinal Diseases in global, including the following market information:
- Global Macular Degeneration (AMD) and Other Retinal Diseases Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Macular Degeneration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Macular Degeneration (AMD) and Other Retinal Diseases include Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma, Merck, Allergan, Santen Pharmaceutical and GlaxoSmithKline Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Macular Degeneration (AMD) and Other Retinal Diseases companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Macular Degeneration (AMD) and Other Retinal Diseases Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Segment Percentages, by Type, 2022 (%)
- Macular Degeneration
- Diabetic Macular Edema
- Diabetic Retinopathy(DR)
- Retinal Vein Occlusion
- Wet Age-Related Macular Degeneration (wAMD)
- Dry Age-Related Macular Degeneration (dAMD)
- Other
Global Macular Degeneration (AMD) and Other Retinal Diseases Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Segment Percentages, by Application, 2022 (%)
Global Macular Degeneration (AMD) and Other Retinal Diseases Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Macular Degeneration (AMD) and Other Retinal Diseases Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Macular Degeneration (AMD) and Other Retinal Diseases revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Macular Degeneration (AMD) and Other Retinal Diseases revenues share in global market, 2022 (%)
key players include:
- Regeneron Pharmaceuticals
- Bayer HealthCare
- Novartis
- Roche
- Kanghong Pharma
- Merck
- Allergan
- Santen Pharmaceutical
- GlaxoSmithKline Pharmaceuticals
- Pfizer
- Acucela
- Valent Pharmaceuticals
- IVERIC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Macular Degeneration (AMD) and Other Retinal Diseases, market overview.
Chapter 2: Global Macular Degeneration (AMD) and Other Retinal Diseases market size in revenue.
Chapter 3: Detailed analysis of Macular Degeneration (AMD) and Other Retinal Diseases company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Macular Degeneration (AMD) and Other Retinal Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
